Shugoshin 1 expression in various cancers: a potential target for therapy

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Shugoshin 1 (SGO1) is crucial for centromere protection and chromosome segregation during cell division.
• Altered SGO1 expression is linked to various cancers and genetic disorders, indicating its therapeutic potential.

Purpose of the Study:

• To review the literature on SGO1 gene and protein expression in diverse cancer models.
• To evaluate the efficacy of targeting SGO1 using siRNA/shRNA in cancer therapy.

Main Methods:

• Literature review of SGO1 expression in cancer cell lines, animal models, and patient tissues.
• Analysis of SGO1 targeting using small interfering RNA (siRNA) and short hairpin RNA (shRNA).

Main Results:

• Elevated SGO1 mRNA and protein levels were observed across multiple cancer types (prostate, renal, lung, breast, etc.), correlating with increased proliferation, invasion, and metastasis.
• SGO1 knockout/haploinsufficiency in mice led to chromosome instability and tumorigenesis.
• Higher SGO1 expression in patient tumors correlated with advanced stage, grade, size, and hormonal status, and was associated with chemoresistance.
• SGO1 knockdown via siRNA/shRNA reduced cancer cell proliferation, induced apoptosis, and enhanced sensitivity to chemotherapeutic agents.

Conclusions:

• SGO1 is significantly upregulated in various cancers, acting as a driver of tumor progression.
• Targeting SGO1 with siRNA/shRNA represents a promising therapeutic strategy to inhibit cancer growth, metastasis, and overcome chemoresistance.